Viewing Study NCT01722266

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-05-30 @ 5:44 AM
Study NCT ID: NCT01722266
Status: COMPLETED
Last Update Posted: 2024-01-05
First Post: 2012-11-02
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Liraglutide in the Treatment of Type 1 Diabetes Mellitus
Sponsor: University at Buffalo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 1 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Liraglutide View
None Glucagon View
None Systolic blood pressure View
None Weight View
None Carbohydrate intake View
None Insulin dose View
None HbA1c View
None Post-prandial glucagon View